BRMS1 sensitizes breast cancer cells to ATP-induced growth suppression

Yue Zhang, Karis Chin-Quee, Ryan Riddle, Zhongyong Li, Zhiyi Zhou, Henry J. Donahue

Research output: Contribution to journalArticle

Abstract

Purinergic signaling may represent an effective target in cancer therapy because the expression of purinergic receptors is altered in many forms of cancer and extracellular nucleotides modulate cancer cell growth. We examined the effect of extracellular ATP on the growth of the metastatic breast carcinoma cell line MDA-MB-435 relative to an immortalized breast epithelial cell line, hTERT-HME1. We also investigated whether the metastasis suppressor gene BRMS1 alters the sensitivity of breast cancer cells to ATP. Exposure to ATP for 24 h decreased proliferation and induced apoptosis in hTERT-HME1. However, exposure to ATP did not decrease proliferation or induce apoptosis in MDA-MD-435 cells until 48 h of exposure and only at higher doses than were effective with hTERT-HME1, suggesting MDA-MB-435 cells were resistant to the antiproliferative and apoptosis-inducing effects of ATP. Exposure to ATP for 24 h induced a decrease in proliferation of MDA-MB-435 cells expressing BRMS1, similar to hTERT-HME1, but did not induce an increase in apoptosis. MDA-MB-435 cells expressed low levels of the purinergic receptor P2Y2, as well as decreased ATP-induced cytosolic calcium mobilization, relative to hTERT-HME1. However, expressing BRMS1 in MDA-MB-435 cells restored P2Y2 levels and ATP-induced cytosolic calcium mobilization such that they were similar to hTERT-HME1. These data suggest that BRMS1 increases the sensitivity of breast cancer cells to the antiproliferative, but not apoptosis-inducing effects of ATP and that this is at least partly mediated by increased expression of the P2Y2 receptor.

Original languageEnglish (US)
Pages (from-to)77-83
Number of pages7
JournalBioResearch Open Access
Volume2
Issue number2
DOIs
StatePublished - Apr 1 2013

Fingerprint

Adenosine Triphosphate
Cells
Breast Neoplasms
Growth
Apoptosis
Purinergic P2Y2 Receptors
Calcium
Purinergic Receptors
Cell Line
Neoplasms
Cell growth
Tumor Suppressor Genes
Breast
Nucleotides
Genes
Epithelial Cells

Keywords

  • apoptosis
  • hTERT-HME1
  • MDA-MB-435
  • purinergic receptors

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

BRMS1 sensitizes breast cancer cells to ATP-induced growth suppression. / Zhang, Yue; Chin-Quee, Karis; Riddle, Ryan; Li, Zhongyong; Zhou, Zhiyi; Donahue, Henry J.

In: BioResearch Open Access, Vol. 2, No. 2, 01.04.2013, p. 77-83.

Research output: Contribution to journalArticle

Zhang, Yue ; Chin-Quee, Karis ; Riddle, Ryan ; Li, Zhongyong ; Zhou, Zhiyi ; Donahue, Henry J. / BRMS1 sensitizes breast cancer cells to ATP-induced growth suppression. In: BioResearch Open Access. 2013 ; Vol. 2, No. 2. pp. 77-83.
@article{f7fc4e1c20fd431c8d4028e156b6067f,
title = "BRMS1 sensitizes breast cancer cells to ATP-induced growth suppression",
abstract = "Purinergic signaling may represent an effective target in cancer therapy because the expression of purinergic receptors is altered in many forms of cancer and extracellular nucleotides modulate cancer cell growth. We examined the effect of extracellular ATP on the growth of the metastatic breast carcinoma cell line MDA-MB-435 relative to an immortalized breast epithelial cell line, hTERT-HME1. We also investigated whether the metastasis suppressor gene BRMS1 alters the sensitivity of breast cancer cells to ATP. Exposure to ATP for 24 h decreased proliferation and induced apoptosis in hTERT-HME1. However, exposure to ATP did not decrease proliferation or induce apoptosis in MDA-MD-435 cells until 48 h of exposure and only at higher doses than were effective with hTERT-HME1, suggesting MDA-MB-435 cells were resistant to the antiproliferative and apoptosis-inducing effects of ATP. Exposure to ATP for 24 h induced a decrease in proliferation of MDA-MB-435 cells expressing BRMS1, similar to hTERT-HME1, but did not induce an increase in apoptosis. MDA-MB-435 cells expressed low levels of the purinergic receptor P2Y2, as well as decreased ATP-induced cytosolic calcium mobilization, relative to hTERT-HME1. However, expressing BRMS1 in MDA-MB-435 cells restored P2Y2 levels and ATP-induced cytosolic calcium mobilization such that they were similar to hTERT-HME1. These data suggest that BRMS1 increases the sensitivity of breast cancer cells to the antiproliferative, but not apoptosis-inducing effects of ATP and that this is at least partly mediated by increased expression of the P2Y2 receptor.",
keywords = "apoptosis, hTERT-HME1, MDA-MB-435, purinergic receptors",
author = "Yue Zhang and Karis Chin-Quee and Ryan Riddle and Zhongyong Li and Zhiyi Zhou and Donahue, {Henry J.}",
year = "2013",
month = "4",
day = "1",
doi = "10.1089/biores.2012.0260",
language = "English (US)",
volume = "2",
pages = "77--83",
journal = "BioResearch Open Access",
issn = "2164-7860",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - BRMS1 sensitizes breast cancer cells to ATP-induced growth suppression

AU - Zhang, Yue

AU - Chin-Quee, Karis

AU - Riddle, Ryan

AU - Li, Zhongyong

AU - Zhou, Zhiyi

AU - Donahue, Henry J.

PY - 2013/4/1

Y1 - 2013/4/1

N2 - Purinergic signaling may represent an effective target in cancer therapy because the expression of purinergic receptors is altered in many forms of cancer and extracellular nucleotides modulate cancer cell growth. We examined the effect of extracellular ATP on the growth of the metastatic breast carcinoma cell line MDA-MB-435 relative to an immortalized breast epithelial cell line, hTERT-HME1. We also investigated whether the metastasis suppressor gene BRMS1 alters the sensitivity of breast cancer cells to ATP. Exposure to ATP for 24 h decreased proliferation and induced apoptosis in hTERT-HME1. However, exposure to ATP did not decrease proliferation or induce apoptosis in MDA-MD-435 cells until 48 h of exposure and only at higher doses than were effective with hTERT-HME1, suggesting MDA-MB-435 cells were resistant to the antiproliferative and apoptosis-inducing effects of ATP. Exposure to ATP for 24 h induced a decrease in proliferation of MDA-MB-435 cells expressing BRMS1, similar to hTERT-HME1, but did not induce an increase in apoptosis. MDA-MB-435 cells expressed low levels of the purinergic receptor P2Y2, as well as decreased ATP-induced cytosolic calcium mobilization, relative to hTERT-HME1. However, expressing BRMS1 in MDA-MB-435 cells restored P2Y2 levels and ATP-induced cytosolic calcium mobilization such that they were similar to hTERT-HME1. These data suggest that BRMS1 increases the sensitivity of breast cancer cells to the antiproliferative, but not apoptosis-inducing effects of ATP and that this is at least partly mediated by increased expression of the P2Y2 receptor.

AB - Purinergic signaling may represent an effective target in cancer therapy because the expression of purinergic receptors is altered in many forms of cancer and extracellular nucleotides modulate cancer cell growth. We examined the effect of extracellular ATP on the growth of the metastatic breast carcinoma cell line MDA-MB-435 relative to an immortalized breast epithelial cell line, hTERT-HME1. We also investigated whether the metastasis suppressor gene BRMS1 alters the sensitivity of breast cancer cells to ATP. Exposure to ATP for 24 h decreased proliferation and induced apoptosis in hTERT-HME1. However, exposure to ATP did not decrease proliferation or induce apoptosis in MDA-MD-435 cells until 48 h of exposure and only at higher doses than were effective with hTERT-HME1, suggesting MDA-MB-435 cells were resistant to the antiproliferative and apoptosis-inducing effects of ATP. Exposure to ATP for 24 h induced a decrease in proliferation of MDA-MB-435 cells expressing BRMS1, similar to hTERT-HME1, but did not induce an increase in apoptosis. MDA-MB-435 cells expressed low levels of the purinergic receptor P2Y2, as well as decreased ATP-induced cytosolic calcium mobilization, relative to hTERT-HME1. However, expressing BRMS1 in MDA-MB-435 cells restored P2Y2 levels and ATP-induced cytosolic calcium mobilization such that they were similar to hTERT-HME1. These data suggest that BRMS1 increases the sensitivity of breast cancer cells to the antiproliferative, but not apoptosis-inducing effects of ATP and that this is at least partly mediated by increased expression of the P2Y2 receptor.

KW - apoptosis

KW - hTERT-HME1

KW - MDA-MB-435

KW - purinergic receptors

UR - http://www.scopus.com/inward/record.url?scp=84958938322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958938322&partnerID=8YFLogxK

U2 - 10.1089/biores.2012.0260

DO - 10.1089/biores.2012.0260

M3 - Article

AN - SCOPUS:84958938322

VL - 2

SP - 77

EP - 83

JO - BioResearch Open Access

JF - BioResearch Open Access

SN - 2164-7860

IS - 2

ER -